Review
Copyright ©The Author(s) 2025.
World J Psychiatry. Aug 19, 2025; 15(8): 107885
Published online Aug 19, 2025. doi: 10.5498/wjp.v15.i8.107885
Table 1 Distinct mediating pathways of stigma and their impact on treatment adherence
Mediating pathway
Mechanism of action
Impact on outcomes
Group differences
Ref.
External stigma → medication literacy → adherenceSocial exclusion restructures access to health information through institutional discriminationPatients avoid reading medication inserts, leading to reduced accuracy in understanding drug interactions; an "information desert" emergesCultural specificity exacerbates information-processing difficulties; women may face more barriers in accessing health information[18-20]
Internalized stigma → self-efficacy → adherenceSelf-stigmatization undermines treatment confidence via cognitive fusionPatients pathologically associate HIV status with self-worth, showing a "self-punishment" tendency in treatment decisionsInternalized stigma is positively correlated with psychological inflexibility, associated with reduced gray matter density in the anterior insula[23,24]
Moderating effects of stigmaMultiple discrimination experiences in racial and sexual minority groupsAfrican American patients exhibit greater distrust toward prescribing intentions; sexual minorities experience unique spatiotemporal stigma burdensAfrican Americans face dual discrimination (race + HIV status); men who have sex with men report higher internalized stigma in family contexts; transgender women experience a triple-layered stigma effect[21,27]
Concealment of treatment behaviorPatients adopt systematic concealment strategies to reduce identity exposure riskStrategies such as altering appointment times or modifying medical records increase complexity and risk in health managementWomen are more likely to use "medication repackaging" due to family role conflicts; men who have sex with men build anonymous support systems through virtual networks[62-65]
Table 2 Key psychosocial mediating variables influencing treatment adherence in people living with human immunodeficiency virus
Mediating variable
Definition
Mediating mechanism
Key findings
Ref.
StigmaSocial stigma and self-stigmatization related to HIVAffects access to health information and self-efficacy through external and internal stigma pathwaysStigma leads to avoidance of medication information and increased risk of dosage errors; internalized stigma is significantly associated with psychological inflexibility[21,22]
Self-efficacyPatients’ belief in their ability to successfully perform treatment behaviorsPromotes translation of health knowledge into treatment behaviors via the self-regulatory system in social cognitive theoryHigher self-efficacy is significantly associated with better adherence; treatment success reinforces efficacy, forming a positive feedback loop[31,32]
Social supportSupport from peers, family, and healthcare providersProvides emotional and informational support, buffers stigma, and enhances self-efficacyPeer support is strongly linked to long-term retention, adherence, and viral suppression; family support buffers the negative impact of low medication literacy on adherence[52,53]
Depression/anxietyMental health problems associated with HIVAlters cognitive processing through functional decoupling of the prefrontal–limbic systemDepression reduces glucose metabolism in the prefrontal cortex, impairing working memory and executive function; anxiety heightens amygdala–insula reactivity, leading to cognitive overload[58-61]
Patient–provider trustDegree of trust patients have in healthcare providersEnhances the therapeutic alliance and reduces suspicion and fear of the medical systemLower levels of trust are linked to poorer adherence and outcomes; especially relevant among minority populations[89]
Table 3 Mechanisms through which self-efficacy mediates the relationship between medication literacy and treatment adherence
Pathway of action
Neural mechanism
Psychological and behavioral manifestations
Influencing factors
Ref.
Medication literacy → self-efficacy → adherenceFunctional coupling between the prefrontal cortex and striatum enhances executive control network efficiencyPatients accurately interpret medication instructions and anticipate side effects, strengthening their sense of agency in disease managementCulturally adapted health education integrates traditional medical beliefs with modern biomedical knowledge, enhancing confidence in medication use[33-35]
Treatment success → reinforced self-efficacy → literacy improvementActivation of D2 receptors in the striatum enhances neural markers of positive behavioral reinforcementPatients consistently achieve micro-level treatment goals, forming a feedback loop of "successful experience → efficacy gain → knowledge deepening"Peer support networks reshape patients’ self-narratives in virtual spaces; trust in healthcare providers modulates dopaminergic projections from the ventral tegmental area to the prefrontal cortex[43-47]
Psychodynamic system of behavioral reinforcementPositive feedback in the dopaminergic reward system drives the acquisition and maintenance of treatment-adherent behaviorHigh-efficacy patients exhibit a 40% increase in behavioral reinforcement learning rate, especially in managing side effectsUrban living environments offer real-time medical feedback channels; economic empowerment frees cognitive resources for health management[59,72]
Dynamic evolution of self-efficacyStage-based construction of efficacy across theoretical modelsIn the initiation phase, trust in healthcare providers plays a central role; in the maintenance phase, the influence of peer support networks increasesDigital interventions using virtual reality simulate medication-taking scenarios, overcoming spatial and temporal limitations of traditional interventions[61]
Table 4 Mechanisms through which social support networks influence treatment adherence in people living with human immunodeficiency virus
Type of support
Mechanism of action
Key research findings
Implications for intervention
Ref.
Peer supportBuffers HIV-related stigma through emotional and informational supportStrongly associated with long-term retention, adherence, and viral suppression among people living with HIV; reduces internalized stigmaDevelop peer-based support networks, especially virtual support communities[47,50,51]
Family supportServes as a buffering variable between literacy and adherence, providing emotional and practical aidMitigates the negative effects of low medication literacy on adherence; improves adherence through medication reminders and accompaniment to careInvolve family members in medication supervision, especially for children and adolescents[53]
Patient–provider trustPromotes adherence by reducing patients’ suspicion and fear toward the healthcare systemLower trust is linked to poorer adherence and treatment outcomes; particularly affects racial and ethnic minority groupsEnhance provider communication skills and adopt culturally adaptive strategies[56]
Community support networksMitigate the negative effects of spatial exclusion by creating alternative healthcare pathwaysCommunity health workers play a key role in sustaining access to antiretroviral therapy; stigma at the community level shapes care-seeking geographyImplement task-sharing interventions with lay providers; build destigmatized support networks[87]
Table 5 Research limitations and future directions
Limitation
Specific issues
Future research directions
Suggestions for innovative methods
Ref.
Lack of longitudinal dataExisting studies predominantly adopt cross-sectional designs, limiting the ability to capture dynamic relationships between psychosocial factors and treatment adherenceEstablish longitudinal cohorts integrating biomarkers with behavioral monitoringUse mobile health technologies for real-time data collection; adopt mixed-method approaches to capture dynamic fluctuations of mediating variables[100,101]
Methodological constraints in quantifying mediation effectsThe complexity of multiple mediation models challenges traditional statistical methods; failure to account for intergroup heterogeneity may bias effect estimatesDevelop hybrid models integrating computational psychiatry and structural equation modelingUse bias-corrected bootstrap methods to relax normality assumptions in mediation testing; apply Bayesian approaches to improve the accuracy of multilevel mediation models[102-106]
Blind spots in evaluating long-term effects of digital interventionsCurrent digital health studies mainly focus on short-term adherence improvements, lacking exploration of behavior maintenance mechanismsConstruct a "digital intervention life-cycle" evaluation frameworkLeverage blockchain technology for decentralized data tracking; include neuroplasticity markers as biomarkers of long-term intervention efficacy[107-108]
Insufficient comparative research on cross-cultural interventionsLack of systematic comparisons of intervention effectiveness across different cultural contextsDevelop a three-dimensional evaluation framework for cross-cultural intervention outcomesCompare prefrontal–limbic system responses to intervention stimuli across cultural groups; analyze the impact of geographic patterns of community-level stigma on delivery efficiency; evaluate the transferability of cultural archetypes in virtual health communities